Home › Medulloblastoma › Alabama
Medulloblastoma clinical trials in Alabama
3 studies for Medulloblastoma are looking for participants at sites in Alabama.
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388Digoxin Medulloblastoma Study
- University of Alabama at Birmingham Children's of Alabama, Birmingham
RecruitingPhase 2
12 Months – 30 Years · All sexes · Updated Aug 26, 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- USA Health Strada Patient Care Center, Mobile
RecruitingPhase 3
Ages 4 to 21 · All sexes · Updated Aug 25, 2026 · NCT05382338From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.